Active Biotech AB Total Assets

Latest as of June 2026: Skr47.90 Million SEK ≈ $5.15 Million USD

Active Biotech AB total assets. Based on the latest financial reports, Active Biotech AB (ACTI) holds total assets worth Skr47.90 Million SEK (≈ $5.15 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Active Biotech AB market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Active Biotech AB (2000–2025)

Total assets of Active Biotech AB from 2000 to 2025. This chart illustrates how Active Biotech AB's total assets have evolved over time, based on quarterly financial data. See Active Biotech AB stock price for real-time trading data and today's change.

Active Biotech AB - Asset Composition Analysis

Active Biotech AB Total Assets Breakdown (December 2025)

Active Biotech AB total assets breakdown as of December 2025. Active Biotech AB's total assets of Skr47.90 Million consist of 96.3% current assets and 3.7% non-current assets.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr65.10 Million	92.7%
Accounts Receivable	Skr2.50 Million	3.6%
Inventory	Skr0.00	0.0%
Property, Plant & Equipment	Skr2.00 Million	2.9%
Intangible Assets	Skr245.00K	0.4%
Goodwill	Skr0.00	0.0%

Asset Composition Trend (2000–2025)

This chart illustrates how Active Biotech AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Active Biotech AB short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Active Biotech AB's current assets represent 96.3% of total assets in 2025, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 92.7% of total assets in 2025, up from 11.5% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 5.0% in 2000.
Asset Diversification: The largest asset category is cash and equivalents at 92.7% of total assets.

Active Biotech AB Competitors by Total Assets

Key competitors of Active Biotech AB based on total assets are shown below.

Company	Country	Total Assets
Hyloris Developmentsen Sa BR:HYL	Belgium	€37.05 Million
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$11.72 Billion
Oruka Therapeutics, Inc. NASDAQ:ORKA	USA	$1.14 Billion
Gempharmatech Co. Ltd. A SHG:688046	China	CN¥2.80 Billion
Vor Biopharma Inc NASDAQ:VOR	USA	$481.05 Million
Inventiva S.A PA:IVA	France	€249.51 Million
Sunmax Biotechnology Co Ltd TWO:4728	Taiwan	NT$1.90 Billion
Apnimed, Inc. Common Stock NASDAQ:APMD	USA	$342.63 Million

Active Biotech AB - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	4.34	1.71	7.33
Quick Ratio	4.34	1.71	7.67
Cash Ratio	0.00	1.47	6.98
Working Capital	Skr35.40 Million	Skr8.10 Million	Skr62.00 Million

Active Biotech AB - Advanced Valuation Insights

This section examines the relationship between Active Biotech AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.92
Latest Market Cap to Assets Ratio	0.17
Asset Growth Rate (YoY)	62.5%
Total Assets	Skr70.20 Million
Market Capitalization	$11.63 Million USD

Valuation Analysis

Below Book Valuation: The market values Active Biotech AB's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Active Biotech AB's assets grew by 62.5% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Active Biotech AB (2000–2025)

The table below shows the annual total assets of Active Biotech AB from 2000 to 2025.

Year	Total Assets	Change
2025-12-31	Skr70.20 Million ≈ $7.55 Million	+62.50%
2024-12-31	Skr43.20 Million ≈ $4.65 Million	-1.92%
2023-12-31	Skr44.05 Million ≈ $4.74 Million	-13.64%
2022-12-31	Skr51.01 Million ≈ $5.49 Million	-10.21%
2021-12-31	Skr56.80 Million ≈ $6.11 Million	+76.66%
2020-12-31	Skr32.16 Million ≈ $3.46 Million	-51.97%
2019-12-31	Skr66.95 Million ≈ $7.21 Million	-77.86%
2018-12-31	Skr302.43 Million ≈ $32.55 Million	-0.45%
2017-12-31	Skr303.81 Million ≈ $32.70 Million	-26.42%
2016-12-31	Skr412.88 Million ≈ $44.43 Million	-8.14%
2015-12-31	Skr449.44 Million ≈ $48.37 Million	-37.80%
2014-12-31	Skr722.52 Million ≈ $77.75 Million	-5.90%
2013-12-31	Skr767.81 Million ≈ $82.63 Million	+10.20%
2012-12-31	Skr696.74 Million ≈ $74.98 Million	-18.84%
2011-12-31	Skr858.52 Million ≈ $92.39 Million	+70.65%
2010-12-31	Skr503.10 Million ≈ $54.14 Million	+0.92%
2009-12-31	Skr498.50 Million ≈ $53.65 Million	+5.40%
2008-12-31	Skr472.95 Million ≈ $50.90 Million	-3.39%
2007-12-31	Skr489.54 Million ≈ $52.68 Million	+5.87%
2006-12-31	Skr462.40 Million ≈ $49.76 Million	-18.57%
2005-12-31	Skr567.86 Million ≈ $61.11 Million	+81.49%
2004-12-31	Skr312.89 Million ≈ $33.67 Million	-9.41%
2003-12-31	Skr345.40 Million ≈ $37.17 Million	-26.12%
2002-12-31	Skr467.50 Million ≈ $50.31 Million	-37.48%
2001-12-31	Skr747.74 Million ≈ $80.47 Million	-13.95%
2000-12-31	Skr868.95 Million ≈ $93.51 Million	--

About Active Biotech AB

ST:ACTI Sweden Biotechnology

Market Cap

$11.63 Million

Skr108.08 Million SEK

Market Cap Rank

#26527 Global

#557 in Sweden

Share Price

Skr4.10

Change (1 day)

+2.50%

52-Week Range

Skr0.04 - Skr7.20

All Time High

Skr28.53